{"DataElement":{"publicId":"7626877","version":"1","preferredName":"Histologic Inflammation Severity Geboes Grading System Score","preferredDefinition":"Histological assessment of inflammation in ulcerative colitis using Geboes grading scale where the score is determined by the level of abnormality in six categories: structural change, chronic inflammation, lamina propria neutrophils, neutrophils in epithelium, crypt destruction, and erosions or ulcers.","longName":"HIST_INF_SEV_GEBOES_GR_SYST_SC","context":"DCP","contextVersion":"1","DataElementConcept":{"publicId":"7626874","version":"1","preferredName":"Histologic Inflammation Severity","preferredDefinition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues._A finding of a localized protective response resulting from injury or destruction of tissues. Inflammation serves to destroy, dilute, or wall off both the injurious agent and the injured tissue. In the acute phase, inflammation is characterized by the signs of pain, heat, redness, swelling, and loss of function. Histologically, inflammation involves a complex series of events, including dilatation of arterioles, capillaries, and venules, with increased permeability and blood flow; exudation of fluids, including plasma proteins; and leukocyte migration into the site of inflammation._Severity; used of the degree of something undesirable e.g. pain or weather.","longName":"7626872v1.0:2512803v1.0","context":"DCP","contextVersion":"1","ObjectClass":{"publicId":"7626872","version":"1","preferredName":"Histologic Inflammation","preferredDefinition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.:A finding of a localized protective response resulting from injury or destruction of tissues. Inflammation serves to destroy, dilute, or wall off both the injurious agent and the injured tissue. In the acute phase, inflammation is characterized by the signs of pain, heat, redness, swelling, and loss of function. Histologically, inflammation involves a complex series of events, including dilatation of arterioles, capillaries, and venules, with increased permeability and blood flow; exudation of fluids, including plasma proteins; and leukocyte migration into the site of inflammation.","longName":"C25526:C3137","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Inflammation","conceptCode":"C3137","definition":"A finding of a localized protective response resulting from injury or destruction of tissues. Inflammation serves to destroy, dilute, or wall off both the injurious agent and the injured tissue. In the acute phase, inflammation is characterized by the signs of pain, heat, redness, swelling, and loss of function. Histologically, inflammation involves a complex series of events, including dilatation of arterioles, capillaries, and venules, with increased permeability and blood flow; exudation of fluids, including plasma proteins; and leukocyte migration into the site of inflammation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF62C641-678D-7CEE-E053-4EBD850A4413","latestVersionIndicator":"Yes","beginDate":"2021-04-07","endDate":null,"createdBy":"TITARENKOI","dateCreated":"2021-04-07","modifiedBy":"ONEDATA","dateModified":"2021-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2512803","version":"1","preferredName":"Severity","preferredDefinition":"Used of the degree of something undesirable e.g. pain or weather; also, strictness.","longName":"C25676","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Severity","conceptCode":"C25676","definition":"Used of the degree of something undesirable e.g. pain or weather; also, strictness.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B8A7FBE-1E7D-31D6-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-21","endDate":null,"createdBy":"UMLLOADER_AGNIS","dateCreated":"2006-08-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF62C641-679B-7CEE-E053-4EBD850A4413","latestVersionIndicator":"Yes","beginDate":"2021-04-07","endDate":null,"createdBy":"TITARENKOI","dateCreated":"2021-04-07","modifiedBy":"TITARENKOI","dateModified":"2021-05-21","changeDescription":"04/07/2021 created for NWU20-02-02 SVAR_ti","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7626876","version":"1","preferredName":"Geboes Grading System Score","preferredDefinition":"A grading scale for histological assessment of inflammation in ulcerative colitis. The score is determined by the level of abnormality in six categories: structural change, chronic inflammation, lamina propria neutrophils, neutrophils in epithelium, crypt destruction, and erosions or ulcers._A number or range of numeric values measuring performance, function, quality, or ability.","longName":"7626876v1.0","context":"DCP","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","minLength":null,"maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7626875","version":"1","preferredName":"Geboes Grading System Score","preferredDefinition":"A grading scale for histological assessment of inflammation in ulcerative colitis. The score is determined by the level of abnormality in six categories: structural change, chronic inflammation, lamina propria neutrophils, neutrophils in epithelium, crypt destruction, and erosions or ulcers.:A number or range of numeric values measuring performance, function, quality, or ability.","longName":"C178552:C25338","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Geboes Grading System","conceptCode":"C178552","definition":"A grading scale for histological assessment of inflammation in ulcerative colitis. The score is determined by the level of abnormality in six categories: structural change, chronic inflammation, lamina propria neutrophils, neutrophils in epithelium, crypt destruction, and erosions or ulcers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF628F23-898C-2FA9-E053-4EBD850A83D7","latestVersionIndicator":"Yes","beginDate":"2021-04-07","endDate":null,"createdBy":"TITARENKOI","dateCreated":"2021-04-07","modifiedBy":"ONEDATA","dateModified":"2021-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF628F23-899D-2FA9-E053-4EBD850A83D7","latestVersionIndicator":"Yes","beginDate":"2021-04-07","endDate":null,"createdBy":"TITARENKOI","dateCreated":"2021-04-07","modifiedBy":"TITARENKOI","dateModified":"2021-05-21","changeDescription":"04/07/2021 created for NWU20-02-02 SVAR_ti","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Geboes Score","type":"Preferred Question Text","description":"Geboes Score","url":null,"context":"DCP"}],"origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF6354E2-405E-3F70-E053-4EBD850A97D1","latestVersionIndicator":"Yes","beginDate":"2021-04-07","endDate":null,"createdBy":"TITARENKOI","dateCreated":"2021-04-07","modifiedBy":"TITARENKOI","dateModified":"2021-05-21","changeDescription":"04/07/2021 created for NWU20-02-02 SVAR_ti","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}